Essilor Instruments, the medical technologies division of the EssilorLuxottica group, brings its
innovations to life through hands-on demonstrations, empowering eye care professionals with cutting-edge tools and real-world expertise.
– Event Highlights –
Vision Expo 2026: Elevating patient care through Essilor Instruments and connected innovation
At Vision Expo 2026, EssilorLuxottica presented a fully connected ecosystem designed to transform patient care and more profoundly, the future of vision care. At the core of the experience was Essilor Instruments, highlighting how advanced diagnostic technologies support next-level patient care.
The showcase featured advanced refraction systems alongside digital charts and vision testing tools that enable highly precise eye exams. It also included solutions from Espansione, further enhancing the treatment ecosystem. Together with lens processing solutions, these innovations demonstrate how precision, efficiency, and clinical insight can elevate every step of the patient journey.
MIDO 2026: An immersive, human-centric experience powered by innovation and technology
MIDO Eyewear Show 2026, EssilorLuxottica delivered an immersive, human-centric experience built around three pillars: Express Yourself, Enhance Life, and See Better, showcasing among others advanced vision care solutions.
Our cutting-edge diagnostic tools, precision measurement technologies, and integrated care solutions empower eye care professionals to deliver more accurate, personalized, and efficient patient outcomes.
.
Vision Expo West 2025: A celebration of innovation and collaboration
At Vision Expo West 2025 in Las Vegas, EssilorLuxottica delivered a high-impact presence with an immersive, interactive booth showcasing cutting-edge innovations. Highlights included new instruments featuring Cellview and Espansione—offering a glimpse into the future of vision care. The presence of eyecare experts further enriched the experience through peer-to-peer exchanges on enhancing practice differentiation and patient outcomes
